[go: up one dir, main page]

AU3074592A - Compositions for delayed treatment of ischemia-related neuronal damage - Google Patents

Compositions for delayed treatment of ischemia-related neuronal damage

Info

Publication number
AU3074592A
AU3074592A AU30745/92A AU3074592A AU3074592A AU 3074592 A AU3074592 A AU 3074592A AU 30745/92 A AU30745/92 A AU 30745/92A AU 3074592 A AU3074592 A AU 3074592A AU 3074592 A AU3074592 A AU 3074592A
Authority
AU
Australia
Prior art keywords
ischemia
compositions
neuronal damage
delayed treatment
related neuronal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30745/92A
Inventor
Robert S. Bitner
Stephen S. Bowersox
James A Fox
George P Miljanich
Karen L Valentino
Donald H Yamashiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Corp PLC
Original Assignee
Neurex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/789,913 external-priority patent/US5559095A/en
Application filed by Neurex Corp filed Critical Neurex Corp
Publication of AU3074592A publication Critical patent/AU3074592A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU30745/92A 1991-11-12 1992-11-12 Compositions for delayed treatment of ischemia-related neuronal damage Abandoned AU3074592A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US789913 1991-11-12
US07/789,913 US5559095A (en) 1989-11-22 1991-11-12 Delayed treatment method of reducing ischemia-related neuronal damage
US91647892A 1992-07-17 1992-07-17
US916478 1992-07-17

Publications (1)

Publication Number Publication Date
AU3074592A true AU3074592A (en) 1993-06-15

Family

ID=27120971

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30745/92A Abandoned AU3074592A (en) 1991-11-12 1992-11-12 Compositions for delayed treatment of ischemia-related neuronal damage

Country Status (2)

Country Link
AU (1) AU3074592A (en)
WO (1) WO1993010145A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2464977C2 (en) * 2006-08-23 2012-10-27 Тзе Юнивесити Оф Монтана Method of reducing demage to nervous cells

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07505908A (en) * 1992-09-28 1995-06-29 マックセチーニ、マリア　ルイザ Allosteric modulator of NMDA receptor
US5591821A (en) * 1993-07-16 1997-01-07 The University Of Utah Omega-conotoxin peptides
US5739276A (en) * 1994-10-07 1998-04-14 University Of Utah Research Foundation Conotoxin peptides
US5670622A (en) * 1996-02-15 1997-09-23 University Of Utah Research Foundation Conotoxin peptide PIIIA
US6054429A (en) * 1996-03-08 2000-04-25 Elan Pharmaceuticals, Inc. Epidural method of producing analgesia
EP1336409B1 (en) * 1995-06-27 2007-04-11 Eisai R&D Management Co., Ltd. Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders
US5965534A (en) * 1995-11-22 1999-10-12 Alcon Laboratories, Inc. Use of ω-conotoxin analogs for treating retinal and optic nerve head damage
US5672682A (en) * 1996-03-18 1997-09-30 University Of Utah Research Foundation Conotoxin peptide PVIIA
US6855805B2 (en) 1999-01-22 2005-02-15 University Of Utah Research Foundation α-conotoxin peptides
AU778353B2 (en) 1999-01-22 2004-12-02 Cognetix, Inc. Alpha-conotoxin peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051403A (en) * 1989-11-22 1991-09-24 Neurex Corporation Method of treating ischemia-related neuronal damage

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2464977C2 (en) * 2006-08-23 2012-10-27 Тзе Юнивесити Оф Монтана Method of reducing demage to nervous cells

Also Published As

Publication number Publication date
WO1993010145A1 (en) 1993-05-27

Similar Documents

Publication Publication Date Title
AU3548795A (en) Benzopyranopyrazolyl derivatives for the treatment of inflammation
AU2187992A (en) Composition and method for disease treatment
AU2718592A (en) Polyolefin compositions and process for their preparation
AU4032989A (en) Method and compositions for the treatment and prevention of septic shock
AU3738293A (en) Compounds useful for treating allergic and inflammatory diseases
IL107039A0 (en) Compositions comprising nomegestrol derivatives and processes for their production
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
AU2228892A (en) Pharmaceutical compositions comprising hydroxamate derivatives for iron removal
IL110201A (en) Pharmaceutical compositions comprising quinoline-3-carboxamide derivatives
AU3074592A (en) Compositions for delayed treatment of ischemia-related neuronal damage
AU8192691A (en) Method of treatment and compositions therefore
AU3328693A (en) Treatment of fungal infections
AU626005B1 (en) Treatment of endometriosis
AU7951591A (en) Methods for treating inflammation and compounds and compositions suitable for use therein
AU3899893A (en) Compositions for the treatment of acute or chronic inflammation
AU3030192A (en) Lip treatment composition
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU4220193A (en) Deazaaminopterins for treatment of inflammation
AU1243392A (en) Prostacycline and carbacycline derivatives as agents for treating feverish complaints
AU5270693A (en) Pharmaceutical composition for preventing or treating arteriosclerosis
NZ242464A (en) 2-aminopyrimidine-4-carboxamide derivatives; preparatory processes and pharmaceutical compositions
AU7770991A (en) Method and composition for the treatment of cancer
AU7155491A (en) Compositions and methods for preventing and treating rotaviral infections
AU5957794A (en) Compositions and method for the inhibition of phagocytes
AU2434992A (en) Methods and compositions for treating sunburns